ELUTIA INC. - CLASS A

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales

08 5 2025 16:05:02 提供 Nasdaq GlobeNewswire

Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio

01 5 2025 16:05:06 提供 Nasdaq GlobeNewswire

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

01 5 2025 08:00:00 提供 Nasdaq GlobeNewswire

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

22 4 2025 16:05:00 提供 Nasdaq GlobeNewswire

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

21 4 2025 08:00:00 提供 Nasdaq GlobeNewswire

Elutia Confirms No Material Impact from Global Tariffs

14 4 2025 08:00:00 提供 Nasdaq GlobeNewswire

EluPro™ Named as 2025 Edison Award Winner

04 4 2025 08:00:00 提供 Nasdaq GlobeNewswire

Elutia to Participate in Upcoming Investor Conferences

03 4 2025 08:00:35 提供 Nasdaq GlobeNewswire

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

02 4 2025 16:05:00 提供 Nasdaq GlobeNewswire

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™

27 3 2025 16:05:23 提供 Nasdaq GlobeNewswire

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope

25 3 2025 16:05:00 提供 Nasdaq GlobeNewswire

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

06 3 2025 16:05:00 提供 Nasdaq GlobeNewswire

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

20 2 2025 16:05:00 提供 Nasdaq GlobeNewswire

Elutia Announces $15.0 Million Registered Direct Offering

03 2 2025 06:30:00 提供 Nasdaq GlobeNewswire

Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand

14 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners

06 1 2025 08:00:01 提供 Nasdaq GlobeNewswire

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

02 12 2024 08:00:00 提供 Nasdaq GlobeNewswire

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

14 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

13 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

29 10 2024 16:05:00 提供 Nasdaq GlobeNewswire